Skip to main content
Clinical Trials/CTRI/2023/01/049237
CTRI/2023/01/049237Not yet recruitingPhase 3

Pharmaceutical analytical and comparative interventional study of ALBU-PRO Bio Enemata(Kukkutanda Basti) and Albumin intervenous infusion in the management of hypoalbuminemia -An open labelled perspective randomized pilot study

Dean Faculty of Ayurved Parul University0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Age between 18 to 80 years.
  • S. Albumin values <3.4 gm/dL
  • Patients irrespective of gender, religion and socio-economic status.

Exclusion Criteria

  • Age of patients less than 18 years and more than 80 years.
  • Any concomitant serious Anorectal disorders(Hemorrhoids, Fissure, anorectal abscess, fistula, cancer, etcâ?¦)
  • Patient having anal incontinence.
  • Gravid women and lactating mothers.
  • Persons is not willing to give inform consent.

Investigators

Sponsor
Dean Faculty of Ayurved Parul University

Similar Trials